electroCore, Inc. (NASDAQ:ECOR) headquartered in Basking Ridge, will host a conference call for the investment community to discuss the 3Q20 financial results on 12th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.electrocore.com
To participate on the live call, please dial 877-407-4018 or 201-689-8471 Outside U.S., when prompted, enter passcode 13711577
Earnings Expectation
electroCore, Inc. is expected to report third quarter earnings results, after market close, on Thursday 12th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.14 per share from revenue of $ 0.94 million. Looking ahead, the full year loss are expected at $ 0.64 per share on the revenues of $ 3.49 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 1.00 million ~ $ 1.00 million
Full Year 2020 topline are forecasted in a range of$ 7.00 million ~ $ 9.00 million
Click Here For More Historical Outlooks Of electroCore, Inc.
electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis.
